Abstract
A technetium-labeled phosphate bone scan was found to detect bone fractures and bone metastasis in the early stages compared to general radiographs. Therefore, bone scans are among the most frequently performed nuclear medical imaging examinations. However, non-osseous radiopharmaceutical uptake on bone scans is unusual. Herein, we report a case of diffuse splenic absorption of Tc-99m dicarboxypropane diphosphonate in patients who underwent liver transplantation.
Figures & Tables
Fig. 1. Bone scan images show increased abnormal osseous uptake (A) on T4, T12, and L2 levels (compression fractures) and (B) left proximal tibia (suggestive traumatic bone lesion). Furthermore, they show increased (C) diffuse splenic uptake of radiopharmaceutical resembling nuclear medicine spleen scan.
